United States Federal Circuit

In a patent dispute arising from defendant's application to commercially sell its generic version of Pfizer's Norvasc drug for hypertension and angina, a judgment in favor of Pfizer finding infringement is reversed where the district court erred in holding that the subject matter of certain patent claims would not have been obvious.

Appellate Information

• Decided 03/22/2007
• Published 03/22/2007

Judges

• MICHEL, Chief Judge., Before MICHEL, Chief Judge, MAYER, and LINN, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• Richard G. Greco, Kay Scholer LLP, of New York, NY, argued for plaintiff-appellee.   With him on the brief were Milton Sherman, Betty A. Ryberg, and Regina O. Kent., Robert B. Breisblatt, Welsh & Katz, Ltd., of Chicago, IL, argued for defendant-appellant.   With him on the brief were A. Sidney Katz, Steven E. Feldman, and Philip D. Segrest, Jr.